Abstract:Background: Contrast-enhanced MRI is the best imaging modality for liver tumor detection and differential diagnosis. However, it is long scan times required and has the contrast agent-associated risks. This study aims to develop and validate a deep convolutional neural network for initial diagnosis of liver tumors based on non-contrast MRI. Methods: In total, 50418 images in enhanced MRI from 1959 patients with liver tumor in three center were enrolled. T2-weighted imaging, diffusion-weighted imaging (DWI), and multiphasic T1-weighted imaging provided input for Inception-ResNet V2 through transfer learning to generate four models for three-way classification. The models was then validated on the independent internal and two external datasets consisting of 5172 and 2916,1338 images, respectively. The diagnostic performance of non-contrast models(T2, T2+DWI) for distinguishing malignancy from benign tumors at-patient level were further evaluated in three validation sets. Findings: Non-contrast models demonstrated similar performance for classifying liver tumors to benign, primary malignant and metastatic tumors, compared with two models based on multi-sequence or enhanced images. In the independent internal cohort, the areas under the receiver operating characteristic curves of T2+DWI model reached 0.91(95% CI,0.888–0.932), 0.873(95% CI,0.848-0.899), and 0.876 (95% CI, 0.840-0.911) for three categories, respectively. At patient-level, the sensitivities of malignant tumors gained from non-contrast models reached 98.1%, 85.7%, 87.5% respectively in three validation sets, while all specificities were almost greater than 70%. Interpretation: This study demonstrates that based on non-contrast MRI, deep learning algorithm can correctly classify liver tumors into benign, primary malignant and metastatic tumors at image-level, and distinguish malignancy from benign with high sensitivity at patient-level, potentially reducing the number of enhanced testing to avoid side effects and financial costs. Funding Statement: This work was supported by grants from National Natural Science Foundation of China (81827804 to X.C.). Declaration of Interests: None. Ethics Approval Statement: This study was approved by the independent institutional review boards of three hospitals and performed according to the Helsinki declaration. The requirement for written informed consent was exempted because of the retrospective nature of this study.

Deep Learning to Distinguish Benign from Malignant Renal Lesions Based on Routine MR Imaging

Title: Deep learning to distinguish benign from malignant renal lesions based on routine MR imaging Authors and affiliations: 1. Ianto

A Deep Learning-Based Radiomics Model for Differentiating Benign and Malignant Renal Tumors

Deep Learning for Accurate Diagnosis of Liver Tumor Based on Magnetic Resonance Imaging and Clinical Data

Classification of Benign and Malignant Renal Tumors Based on CT Scans and Clinical Data Using Machine Learning Methods

Deep Learning-Assisted Diagnosis of Liver Tumors Using Non-Contrast Magnetic Resonance Imaging: A Multi-Center Study

Differentiating Benign from Malignant Renal Tumors Using T2 ‐ and Diffusion‐Weighted Images: A Comparison of Deep Learning and Radiomics Models Versus Assessment from Radiologists

Deep Learning Assessment of Small Renal Masses at Contrast-enhanced Multiphase CT

Distinguishing common renal cell carcinomas from benign renal tumors based on machine learning: comparing various CT imaging phases, slices, tumor sizes, and ROI segmentation strategies

Differentiation of benign from malignant solid renal lesions using CT-based radiomics and machine learning: comparison with radiologist interpretation

Deep Learning Identification of Clear Cell Renal Carcinoma Cancer Using MR Imaging

Deep learning and radiomic feature-based blending ensemble classifier for malignancy risk prediction in cystic renal lesions

A Radiomic-based Machine Learning Algorithm to Reliably Differentiate Benign Renal Masses from Renal Cell Carcinoma

CT-based conventional radiomics and quantification of intratumoral heterogeneity for predicting benign and malignant renal lesions

A Robust Deep Learning Method with Uncertainty Estimation for the Pathological Classification of Renal Cell Carcinoma based on CT Images

Automated Classification of Papillary Renal Cell Carcinoma and Chromophobe Renal Cell Carcinoma Based on a Small Computed Tomography Imaging Dataset Using Deep Learning

Deep learning-based diagnosis and survival prediction of patients with renal cell carcinoma from primary whole slide images

A CT-Based Clinical, Radiological and Radiomic Machine Learning Model for Predicting Malignancy of Solid Renal Tumors (UroCCR-75)

Predicting postoperative prognosis in clear cell renal cell carcinoma using a multiphase CT-based deep learning model

Differentiation of low and high grade renal cell carcinoma on routine MRI with an externally validated automatic machine learning algorithm

Deep learning algorithm (YOLOv7) for automated renal mass detection on contrast-enhanced MRI: a 2D and 2.5D evaluation of results